Advertisement

Topics

Graybug Vision, Inc. Company Profile

07:55 EDT 19th April 2018 | BioPortfolio

Graybug Vision is developing novel products for the treatment of people with ocular diseases. The company’s proprietary injectable products are designed to enable less frequent administration and to reduce the burden of treatment for patients with ocular diseases. The company’s lead product, GB-102, has the potential for twice per year injections to treat patients with neovascular (wet) AMD. Graybug Vision has developed a library of compounds to treat glaucoma, a leading cause of progressive, irreversible vision loss worldwide, by lowering intraocular pressure alone or in combination with neuroprotection when injected twice per year. For more information, please visit www.graybug.com.


News Articles [292 Associated News Articles listed on BioPortfolio]

Graybug Vision to Participate in Upcoming Industry Conferences

Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for vision-threatening diseases including wet (neovascula...

Graybug Vision Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryGraybug Vision Inc Graybug Vision is a venture stage pharmaceutical company that develops products for the treatment of eye diseases. The company's GB102 contains a single small molecule compou...

Young woman presents with acute-onset unilateral vision loss

A 27-year-old marketing professional was seen at Tufts Medical Center emergency department with new-onset vision changes in the right eye. She first noted a change in vision approximately 30 hours bef...

Pixium Vision announces successful implantation and activation of PRIMA Bionic Vision System

Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today the world’s fir...

French Biotech Restores Vision in Humans with Subretinal Implant

Pixium Vision has successfully restored vision in three patients with age-related macular degeneration (AMD) using an implanted wireless device, offering significant improvements to their quality of l...

SEA Vision becomes a partner of the Marchesini Group

The Marchesini Group has signed a 48% acquisition of SEA Vision, a leading creator of vision and inspection systems used in quality control and drug counterfeiting

New NAVRISK VISION 2.0 Release

"The new NAVRISK VISION Release 2.0 provides new usability improvements that streamline key task management, increase productivity and simplify functionality across all NAVRISK VISION platforms," ...

New smartphone app may help patients take better care of their vision at home

Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to resea...

PubMed Articles [346 Associated PubMed Articles listed on BioPortfolio]

Rehabilitation Referral for Patients With Irreversible Vision Impairment Seen in a Public Safety-Net Eye Clinic.

The prevalence of irreversible vision impairment in the United States is expected to increase by 2050. Vision rehabilitation is the primary treatment option. Clinical trials have established its effic...

Vision Screening in Children Aged 6 Months to 5 Years: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Preschool vision screening could allow detection and treatment of vision abnormalities during a critical developmental stage, preserving function and quality of life.

Color Vision 2018: Introduction by the feature editors.

This feature issue of the Journal of the Optical Society of America A (JOSA A) reflects the basic and applied research interests of members of the color vision community. Most of the articles stem fro...

Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement.

One of the most important causes of vision abnormalities in children is amblyopia (also known as "lazy eye"). Amblyopia is an alteration in the visual neural pathway in a child's developing brain that...

Individuals' Perspectives on Coping with Vision Loss from Diabetic Retinopathy.

People with vision loss from diabetic retinopathy (DR) and diabetic macular edema (DME) use problem-focused and emotion-regulation strategies that may influence their short- and longer-term adaptation...

Clinical Trials [652 Associated Clinical Trials listed on BioPortfolio]

Low-vision Rehabilitation Program for Low-vision Patients and Care Givers

To evaluate health related quality of life (HRQoL) of low-vision patients and their care givers undergoing low-vision rehabilitation program (LVRP).

Low Vision Intervention Trial II (LOVIT II)

This study will determine if the interdisciplinary team low vision rehabilitation program is more effective than basic low vision care provided by an optometrist working alone in improving...

Safety Study Looking at the Effects of Stendra on Vision

The purpose of this study is to see if Stendra causes any changes in vision, eye pressure, pupil dilation, and color vision in healthy males.

VA Low Vision Intervention Trial

The primary purpose of this research study is to evaluate the effectiveness of a new outpatient low vision rehabilitation program that is targeted to serve legally blind veterans with cent...

Retina Projection System Trials for Low Vision People

1. Purpose a. Examination on Efficacy of Retina Projection System 2. Patients a. Low vision patients 3. Methods 1. Vision aids ...

Companies [763 Associated Companies listed on BioPortfolio]

Graybug Vision, Inc.

Graybug Vision is developing novel products for the treatment of people with ocular diseases. The company’s proprietary injectable products are designed to enable less freque...

Davis Vision

Headquartered in Plainview, N.Y., Davis Vision is one of America's leading vision benefits companies, providing comprehensive vision benefits for nearly 50 years. More than 55 million individuals nati...

Davis Vision, Inc.

Davis Vision is part of the HVHC Inc. group of companies, which also includes Viva International Group and Eye Care Centers of America. One of the nation's premier managed vision care companies, Davis...

LCA-Vision Inc.

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 62 LasikPlus® fixed-site laser vision correction centers in 29 states and 45 markets in t...

Vision-Sciences, Inc.

Vision-Sciences, Inc. designs, develops, manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths, the Slide-On EndoSheath System, which p...

More Information about "Graybug Vision, Inc." on BioPortfolio

We have published hundreds of Graybug Vision, Inc. news stories on BioPortfolio along with dozens of Graybug Vision, Inc. Clinical Trials and PubMed Articles about Graybug Vision, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Graybug Vision, Inc. Companies in our database. You can also find out about relevant Graybug Vision, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record